Literature DB >> 18667745

A case of desensitization, transplantation, and allograft dysfunction.

Colm Magee1, Michael Clarkson, Helmut Rennke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18667745      PMCID： PMC4571155          DOI： 10.2215/CJN.00920208

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  25 in total

Review 1.  Transplantation across previously incompatible immunological barriers.

Authors:  Colm C Magee
Journal:  Transpl Int       Date:  2006-02       Impact factor: 3.782

2.  Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial.

Authors:  G A Böhmig; M Wahrmann; H Regele; M Exner; B Robl; K Derfler; T Soliman; P Bauer; M Müllner; W Druml
Journal:  Am J Transplant       Date:  2006-11-15       Impact factor: 8.086

3.  Kidney transplantation in patients with antibodies against donor HLA class II.

Authors:  H S Pollinger; M D Stegall; J M Gloor; S B Moore; S R Degoey; N A Ploeger; W D Park; H S Pollinger; M D Stegall; J M Gloor; S B Moore; S R Degoey; N A Ploeger; W D Park
Journal:  Am J Transplant       Date:  2007-02-09       Impact factor: 8.086

4.  Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.

Authors:  S C Jordan; A Vo; S Bunnapradist; M Toyoda; A Peng; D Puliyanda; E Kamil; D Tyan
Journal:  Transplantation       Date:  2003-08-27       Impact factor: 4.939

5.  Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Authors:  Stanley C Jordan; Dolly Tyan; Don Stablein; Matthew McIntosh; Steve Rose; Ashley Vo; Mieko Toyoda; Connie Davis; Ron Shapiro; Deborah Adey; Dawn Milliner; Ralph Graff; Robert Steiner; Gaetano Ciancio; Shobah Sahney; Jimmy Light
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

6.  Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg).

Authors:  Denis Glotz; Corinne Antoine; Pierre Julia; Caroline Suberbielle-Boissel; Samir Boudjeltia; Rabah Fraoui; Chafic Hacen; Alain Duboust; Jean Bariety
Journal:  Am J Transplant       Date:  2002-09       Impact factor: 8.086

7.  Overcoming a positive crossmatch in living-donor kidney transplantation.

Authors:  James M Gloor; Steven R DeGoey; Alvaro A Pineda; S Breanndan Moore; Mikel Prieto; Scott L Nyberg; Timothy S Larson; Matthew D Griffin; Stephen C Textor; Jorge A Velosa; Thomas R Schwab; Lynette A Fix; Mark D Stegall
Journal:  Am J Transplant       Date:  2003-08       Impact factor: 8.086

8.  Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.

Authors:  James M Gloor; Steven DeGoey; Nancy Ploeger; Howard Gebel; Robert Bray; S Breanndan Moore; Patrick G Dean; Mark D Stegall
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

9.  The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.

Authors:  James M Gloor; S Breanndan Moore; Brittany A Schneider; Steven R Degoey; Mark D Stegall
Journal:  Transplantation       Date:  2007-07-27       Impact factor: 4.939

10.  Predicting kidney graft failure by HLA antibodies: a prospective trial.

Authors:  Paul I Terasaki; Miyuki Ozawa
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.